IPKat congratulates three new IP silks
The IPKat team is delighted to hear news of three freshly-gowned members of the IP bar, who have been elevated to Queen’s Counsel in the 2019 “silk round”. In alphabetical order:
- Mark Chacksfield (8 New Square), who represented Abbvie in defending FKB’s claim for an Arrow declaration.
- Lindsay Lane (8 New Square), who appeared for Teva in several generics’ successful challenge to the validity of Gilead’s SPC protecting TRUVADA.
- Brian Nicholson (11 South Square), who appeared for American Science & Engineering in a successful infringement claim and validity defence against Rapiscan Systems.
- Mark Chacksfield (8 New Square), who represented Abbvie in defending FKB’s claim for an Arrow declaration.
- Lindsay Lane (8 New Square), who appeared for Teva in several generics’ successful challenge to the validity of Gilead’s SPC protecting TRUVADA.
- Brian Nicholson (11 South Square), who appeared for American Science & Engineering in a successful infringement claim and validity defence against Rapiscan Systems.
Hearty congratulations to all three, particularly as part of a smaller round than in recent years. [Merpel notes that silk prices have been in declinefor the last six months, so the timing is fortuitous.]